Considerations for quality assurance of multiplex malaria antigen detection assays with large sample sets
Abstract Multiplex assays for malaria antigen detection can gather data from large sample sets, but considerations for the consistency and quality assurance (QA) of mass testing lack evaluation. We present a QA framework for a study occurring November 2019 to March 2020 involving 504 assay plates de...
Guardado en:
Autores principales: | Rachel Alvarado, Lotus L. van den Hoogen, Nnaemeka C. Iriemenam, Oluwaseun O. Akinmulero, Andrew N. Thomas, Israel Tamunonengiyeofori, Evbuomwan Erasogie, Achugbu C. Chimaoge, Ayuba B. Dawurung, Mudiaga K. Esiekpe, Mary U. Okoli, Nwando Mba, Abiodun Ogunniyi, Alash’le Abimiku, Mark Maire, Orji O. Bassey, McPaul Okoye, Mahesh Swaminathan, Stacie M. Greby, Nnaemeka Ndodo, Chikwe Ihekweazu, Ado Abubakar, Laura Steinhardt, Eric Rogier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77e06d2e66de421ea35fbe36e6f0ff2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Community pharmacists on the frontline in the chronic disease management: The need for primary healthcare policy reforms in low and middle income countries
por: Roland Nnaemeka Okoro, et al.
Publicado: (2021) -
Improving the diagnostic recognition of thoracic endometriosis: Spotlight on a new histo-morphological indicator.
por: Okechukwu Charles Okafor, et al.
Publicado: (2021) -
Breaking down barriers for hepatitis B screening in the Bronx West African community through education in collaboration with faith-based organizations: A cohort study
por: Emmanuel U. Emeasoba, et al.
Publicado: (2022) -
Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2020) -
Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2021)